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The transcriptional corepressor complex CoREST is
one of seven histone deacetylase complexes that
regulate the genome through controlling chromatin
acetylation. The CoREST complex is unique in con-
taining both histone demethylase and deacetylase
enzymes, LSD1 and HDAC1, held together by the
RCOR1 scaffold protein. To date, it has been
assumed that the enzymes function independently
within the complex. Now, we report the assembly
of the ternary complex. Using both structural and
functional studies, we show that the activity of the
two enzymes is closely coupled and that the complex
can exist in at least two distinct states with different
kinetics. Electron microscopy of the complex reveals
a bi-lobed structure with LSD1 and HDAC1 enzymes
at opposite ends of the complex. The structure of
CoREST in complex with a nucleosome reveals a
mode of chromatin engagement that contrasts with
previous models.INTRODUCTION
Themolecular machinery that installs and removes post-transla-
tional modifications of chromatin has been the subject of
increasing research interest not least because these protein
complexes are key regulators of gene expression, but they are
also promising drug targets for the epigenetic treatment of can-
cer and other diseases (Delcuve et al., 2012; Hesham et al.,Cell Rep
This is an open access article und2018; Millard et al., 2017; Rowe et al., 2019). It is now well
established that acetylation and methylation of lysine residues
within the tails of histone proteins not only control the recruit-
ment of regulatory factors but also influence the architecture of
chromatin itself. The CoREST complex is one of seven families
of class I histone deacetylase complexes that have specialized
physiological functions but are all thought to act as repressors
of gene expression. CoREST is unique within these complexes
in that it removes both acetyl and methyl modifications through
the activity of its demethylase (LSD1) and deacetylase
(HDAC1) enzymes.
The CoREST complex was initially identified as a cofactor of
the REST/NRSF (RE1-silencing transcription factor/neural-
restrictive silencer factor) transcriptional repressor, which plays
important roles in regulating neuron-specific gene expression
and stem cell fate and development (Andre´s et al., 1999; Ballas
et al., 2001; Foster et al., 2010; Wang et al., 2007). The core of
the CoREST complex contains two histone modification en-
zymes, including histone deacetylase 1 or 2 (Humphrey et al.,
2001; You et al., 2001), lysine specific demethylase LSD1 (Lee
et al., 2005; Shi et al., 2004, 2005), and RCOR1, 2, or 3 that links
the two enzymes. The classic enzymatic target for the CoREST
complex is the histone H3 tail in which K4 is mono- or di-meth-
ylated and K9 is acetylated. Removal of these activating marks
results in transcriptional repression (Andre´s et al., 1999; Lakow-
ski et al., 2006; Lee et al., 2005; You et al., 2001).
The RCOR protein serves as a scaffold for complex assembly
and the recruitment of the complex to the repressive transcrip-
tion factors (Humphrey et al., 2001; Saleque et al., 2007; Shi
et al., 2005; You et al., 2001). RCOR contains an ELM2-SANT1
domain that mediates interaction with the catalytic domain of
HDAC1 (You et al., 2001) and a LINKER-SANT2 domain thatorts 30, 2699–2711, February 25, 2020 ª 2020 The Author(s). 2699
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interacts with the TOWER domain of LSD1 (Shi et al., 2005; Fig-
ure 1A). The RCOR-SANT2 domain has also been proposed to
directly interact with nucleosomal DNA (Pilotto et al., 2015;
Yang et al., 2006).
Multiple crystal structures of LSD1 in complex with the
LINKER-SANT2 of RCOR have revealed the mode of assembly
and the nature of the LSD1 active site and its interaction with
substrates and inhibitors (Baron et al., 2011; Forneris et al.,
2007; Yang et al., 2006, 2007). There is no structure of HDAC1
in complex with RCOR, but a homologous structure of HDAC1
bound to the ELM2-SANT domain of MTA1 likely has many fea-
tures in common (Millard et al., 2013).
Given the dual functionality of the CoREST complex, we sought
to investigate the relationship between the two different enzymes
when assembled together. Such an integrated understanding of
the ternary complex has, to date, been lacking. We have taken a
structural approach to understand the relative positioning of the
two enzymes in the complex and an enzymatic approach to
explore potential crosstalk between the two activities. We have
found that, although the two enzymes are positioned at either
ends of the complex, there is a remarkable coupling between their
enzymatic activities. Inhibitors of one enzyme strongly influence
the kinetics of the partner enzyme, and only one active site can
engage substrate at any one time. It is also apparent that the com-
plex exists in at least two distinct states. Exchange between these
is sensitive to modulators of the complex. Finally, the structure of
CoREST in complex with a nucleosome, in which histone H3K4 is
modified with a propargyl inhibitor, reveals a mode of binding that
is distinct from previous models.
RESULTS
RCOR1, LSD1, and HDAC1 Form a Stable, Enzymatically
Active, Stoichiometric Ternary Complex
Studies of the CoREST complex to date have investigated the in-
dependent activities of the demethylase and deacetylase en-
zymes. To understand the behavior of these enzymes in the
context of the full ternary CoREST complex, we have co-ex-
pressed full-length LSD1 and HDAC1 and a construct of the
RCOR1 corepressor (amino acids [aas] 86–485) lacking only the
N-terminal disordered region. The holo CoREST ternary complex
was purified to homogeneity using an N-terminal FLAG affinity
tag followed by size exclusion chromatography (Figure 1B).
In our previous studies, we have observed that corepressor
complexes containing class I HDACs (SMRT/NCoR, NuRD,
and MiDAC) assemble into either dimeric or tetrameric com-
plexes (Itoh et al., 2015; Millard et al., 2013; Oberoi et al.,
2011). Detailed structural information is available for the crystal
structure of the dimeric MTA1:HDAC1 complex (Millard et al.,
2013)—see alignment (Figure 1C). To determine the oligomeriza-
tion state of the CoREST complex, we used size exclusion chro-
matography coupled with multi-angle light scattering (SEC-
MALS). The overall molecular weight was measured to be
200 kDa (Figure 1D), which correlateswith the predictedmono-
meric molecular weight of 193 kDa (full-length LSD1, 92.9 kDa;
full-length HDAC1, 55.1 kDa; RCOR186–485, 45.1 kDa), indicating
that the full ternary CoREST complex contains a single copy of
HDAC1, LSD1, and RCOR1. A sequence comparison of2700 Cell Reports 30, 2699–2711, February 25, 2020RCOR1–3 with MTA1–3 shows that the ELM2 domain within
RCOR1 lacks the helices that mediate dimerization of MTA1 in
the NuRD corepressor complex (Figure 1C).
To confirm that the ternary complex that we expressed and pu-
rified fromHEK293cells is active, weused fluorogenic enzymeas-
says tomeasure both the deacetylase and demethylase activity of
the complex (Figures 1E and 1F). As controls, we used the HDAC
inhibitors SAHA and MS275 and the demethylase inhibitors 2-
PCPA and SP2509 to confirm that the observed activity could
be inhibited as expected. Several class I HDAC complexes are
activated by inositol phosphates that bind in a pocket between
the corepressor and the HDAC, close to the active site (Itoh
et al., 2015;Millard et al., 2013;Watson et al., 2012, 2016). Inspec-
tion of the sequence of RCOR1 suggests that the inositol phos-
phate binding residues are conserved, and therefore, we would
predict that the CoREST complex would also interact with inositol
phosphates (Figure S1A). To test this, we measured the deacety-
lase activity of the ternary complexes in the absence and pres-
ence of Ins(1,4,5,6)P4 and InsP6. We observed a significant in-
crease in HDAC activity in the presence of both inositol
phosphates, suggesting that these may regulate the HDAC activ-
ity of the CoREST complex (Figure 1E). As for other class I HDAC
complexes, Ins(1,3,4,5,6)P5 also activates HDAC1 in the CoREST
complex (Figure S1B; Watson et al., 2016).
Coupled Kinetics of the LSD1 and HDAC1 Enzymes
within the CoREST Complex
To determine whether the LSD1 and HDAC1 enzymes within the
CoREST complex behave as independent enzymes or whether
they are coupled, a 1H NMR-based assay was developed. In
this assay, demethylation and deacetylation of 21-amino-acid
synthetic peptides corresponding to the N terminus of histone
H3 (with specific post-translational modifications; Table S1) are
monitored in real time. Initially, we used singly modified peptides
containing either mono-methyl K4 (K4meK9) or acetyl K9
(K4K9ac). Peaks corresponding to the methyl protons of
K4me, K9ac, and the free acetate product could readily be
observed and distinguished in one-dimensional 1H NMR spectra
(Figures 2A, 2B, 2F, and 2G). The HDAC and LSD1 inhibitors and
inositol phosphates used in these experiments do not contain
peaks that overlap with the methyl or acetyl peaks. Both deme-
thylase and deacetylase reactions were monitored, with a range
of initial H3 substrate concentrations, by using the intensities of
the K4me and K9ac peaks as reporters on the concentration of
the substrates in real time.
Analysis of the progression curves (Figures 2C, 2D, 2H, 2I, S2,
and S3) for the demethylation of the K4meK9 substrate and the
deacetylation of K4K9ac showed that the reactions do not follow
classical Michaelis-Menten kinetics, but the apparent KM and
kcat parameters are strongly time dependent with biphasic pro-
gression curves. This biphasic behavior is particularly pro-
nounced for the demethylation reaction upon addition of the
HDAC inhibitor MS275 and for the deacetylation reaction upon
addition of the LSD1 inhibitor 2-PCPA. A number of different re-
actions schemes were considered, including those involving
standard substrate and product inhibition (Figure S4A; Tables
S2 and S3). The simplest reaction scheme, which overall gave
satisfactory results for both the demethylation and deacetylation
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Figure 1. The CoREST Complex Forms a Stable, Enzymatically Active, and Stoichiometric Complex
(A) Schematic representation of domain structures of LSD1/KDM1A/AOF2, CoREST/RCOR1, andHDAC1. Gray boxes represent the structured domains. Dashed
lines indicate the interacting regions within the complex.
(B) Co-expression and purification of the LSD1:RCOR1:HDAC1 ternary complex.
(C) Sequence alignment of the ELM2 domain from RCOR1–3 and MTA1–3 proteins. Identical residues are shown in red, and conserved residues are shown in
orange. The predicted secondary structure of RCOR1 is indicated above the sequence (green), and the secondary structure of MTA1 observed in the crystal
structure is indicated below the sequence (yellow).
(D) Stoichiometry/molecular weight determination of the CoREST ternary complex by SEC-MALS.
(E) Deacetylase activity of the ternary complex. As expected, the activity is enhanced by 100 mM Ins(1,4,5,6)P4 (InsP4) and by Ins(1,2, 3,4,5,6)P6 (InsP6). The
activity is inhibited by SAHA and MS275 (5 mM). The activity is normalized (100%) to the basal HDAC activity. The basal activity of the assay with no complex has
been subtracted. Error bars indicate the SEM (n = 3). p values are shown in the form: *** p < 0.001 or **** p < 0.0001.
(F) Demethylase activity of the ternary complex. As expected, the activity is inhibited by 2-PCPA and SP2509 (10 mM). The activity is normalized (100%) to the
basal demethylase activity. The basal activity of the assay with no complex has been subtracted. Error bars indicate the SEM (n = 3). p values are shown in the
form: *** p < 0.001 or **** p < 0.0001.
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Figure 2. Enzymatic Coupling between LSD1 and HDAC1 in the CoREST Complex
(A) The 1H NMR reference spectrum of a 330 mM sample of H3K4me, with the assignment of the K4 N(6) methyl protons shown.
(B) Time series after the addition of 200 nM CoREST complex to the H3K4me substrate.
(C and D) Progression curves for the conversion of ca. 300 mM (C) or 80 mM (D) H3K4me substrate incubated with 200 nM CoREST complex.
(E) Filled circles are experimentally obtained substrate concentrations versus time, full-drawn lines are the results of the least-squares fits to the reaction scheme,
and dashed lines represent the limiting rates after equilibrium is reached.
(F) Reference 1H NMR spectrum of 670 mM H3K9ac with the assignment of the methyl protons of the K9 acetyl group shown.
(G) A representative time series obtained after the addition of 50 nM CoREST complex to a 100 mM sample of H3K9ac. It is noted that both the disappearance of
the H3K9ac substrate and the appearance of the acetate product can be observed, and their concentrations can be quantified from the intensity of the two peaks.
(H and I) Progression curves for ca. 660 mM (H) or 100 mM (I) H3K9ac substrate concentration versus time after addition of 50 nM CoREST.reactions, is shown in Figure 2E. The key feature of this reaction
scheme is that it invokes an alternate state (E*) of the enzymes
(HDAC1 and LSD1), which exhibit different enzymatic parame-
ters. In particular, the first-order catalytic rate, kcat, and the
substrate disassociation rate, k1, are different for E and E*.
Moreover, the model suggests a slow unimolecular exchange
between E and E* and between ES and E*S. For all demethyla-
tion reactions, the catalytic rate from E*S was insignificant (p 
0.8; kcat,E*  0 s1), although kcat,E* > 0 s1 was significant for
all the deacetylation reactions (p of 0.003–0.05). The existence
of an alternate state of the HDAC1 and LSD1 enzymes means
that the overall reaction is highly dependent upon whether
equilibrium has been reached between ES and E*S. When equi-
librium between ES and E*S has been reached, apparent
Michaelis-Menten parameters can be calculated (Supplemental
Information), which are denoted KM,post and kcat,post (Tables 1, 2,
S4, and S5). The dashed lines in Figures 2C, 2D, 2H, and 2I are
calculated based on the limiting condition of long reaction times
and ES# E*S equilibrium.2702 Cell Reports 30, 2699–2711, February 25, 2020As might be expected, addition of the 2-PCPA LSD1 inhibitor
increases the KM,post of the demethylation reaction by approxi-
mately an order of magnitude and also decreases the catalytic
rate by a factor of three, in agreement with the results of the flu-
orogenic assay in Figure 1F. Of particular interest is that the addi-
tion of the HDAC inhibitor MS275 has a profound effect on both
the progression curves (Figures 2C and 2D) and kinetic parame-
ters, obtained for the demethylation of K4meK9. The catalytic
rate post-equilibrium, kcat,post, is only marginally affected, as is
the equilibrium between ES and E*S. However, KM,post is about
a factor of four larger and the rate E/ E* is a factor of three
slower. This change clearly indicates a coupling between LSD1
and HDAC1 within the CoREST complex and leads to a slower
convergence toward the KM,post and kcat,post parameters, which
is clearly visible in the experimental progression curves. These
findings indicate a negative regulation, where once inhibitor or
substrate is bound to HDAC1, the binding affinity for substrate
to LSD1 decreases, which is also in agreement with previous ob-
servations that trichostatin A inhibited demethylation of
Table 1. Summary of Kinetic Parameters Obtained for the
Demethylation of K4meK9 by CoREST
APO 2-PCPAa MS275b InsP6
c
Post-equilibrium Apparent Parameters
kcat,post (s
1) 0.032 ±
0.002
0.0077 ±
0.0012
0.023 ±
0.003
0.093 ±
0.007
KM,post (mM) 2.3 ±
1.7
26 ± 5 9.2 ±
1.6
190 ±
30
kcat,post/KM,post (s
1mM1) 14 ± 7 0.30 ±
0.02
2.5 ±
0.4
0.48 ±
0.04
Unimolecular Exchange
Keq(E) 7.0 ±
2.4
7.4 ±
0.5
1.7 ±
0.6
3.0 ±
0.3
kex(E) (s
1) 0.0074 ±
0.0024
<5 3 104 0.0028 ±
0.0015
0.0015 ±
0.0013
Keq(ES) 76 ± 28 129 ±
30
146 ±
38
49 ± 4
kex(ES) (s
1) 0.0055 ±
0.0012
0.0050 ±
0.0008
0.0060 ±
0.0024
0.047 ±
0.020
aThe 200 nM CoREST complex was pre-equilibrated with 0.1 mM 2-
PCPA LSD1 inhibitor.
bThe CoREST complex was pre-equilibrated with 5 mMMS275 HDAC in-
hibitor.
cThe CoREST complex was pre-equilibrated with 0.1 mM InsP6.
Table 2. Kinetic Parameters Obtained for the Deacetylation of
K4K9ac by CoREST
APO 2-PCPAa InsP6
b
Post-equilibrium Apparent Parameters
kcat,post (s
1) 0.70 ±
0.03
0.52 ±
0.05
0.78 ±
0.18
KM,post (mM) 33 ± 6 22 ± 4 12 ± 5
kcat,post/KM,post (s
1mM1) 21 ± 2 23 ± 3 70 ± 50
Unimolecular Exchange
Keq(E) 6.8 ± 2.3 5.5 ±
2.2
1.9 ±
2.1
kex(E) (s
1) <107 0.0031 ±
0.0017
0.14 ±
0.17
Keq(ES) 2,560 ±
1,620
280 ±
220
1,990 ±
1,600
kex(ES) (s
1) 0.077 ±
0.042
0.0028 ±
0.0016
0.09 ±
0.07
aThe CoREST complex was pre-equilibrated with 0.1 mM 2-PCPA LSD1
inhibitor.
bThe CoREST complex was pre-equilibrated with 0.1 mM InsP6.nucleosomes (Lee et al., 2006). Addition of InsP6 also has a sub-
stantial effect on the demethylase progression curves and
derived kinetic parameters. Most remarkable is an increase of
about two orders of magnitude in the post-equilibrium apparent
Michaelis-Menten constant for KM,post and an order of magni-
tude increase in the kex(ES) rate such that the equilibrium be-
tween ES and E*S is reached nearly within the dead time of the
experiment. The obtained parameters means that, at high con-
centrations of substrate ([S]0 > 200 mM), addition of InsP6 in-
creases the effective rate, although for lower substrate concen-
trations ([S]0 < 100 mM), addition of InsP6 slows the effective
reaction rate.
The progression curves for the deacetylation of K4K9ac by
CoREST are shown in Figures 2H and 2I for apo CoREST and
for CoREST pre-incubated with the three modulators 2-PCPA,
MS275, and InsP6. The progression curves were analyzed using
the same reaction scheme as shown in Figure 2E, with the
exception of the experiments in which CoREST is incubated
with theHDAC inhibitorMS275, for which no reliable deacetylase
parameters could be obtained. The equilibrium constants be-
tween E and E* are essentially identical for the demethylation
and the deacetylation reactions under the various conditions
(Tables 1 and 2). The addition of InsP6 results in an increase of
kcat,post/KM,post by a factor of three, which is in agreement with
the results from the fluorogenic assay in Figure 1E. Most sub-
stantial is that the addition of InsP6 leads to a dramatic increase
in the exchange rate between E and E*. This effect is in line with
the demethylation reaction where the addition of InsP6 leads to a
substantial change in the exchange rates between both ES#
E*S and E# E*.
Although both the deacetylation and the demethylation reac-
tions are best described by the reaction scheme in Figure 2E,the alternate states, E and E*, need not necessarily be the
same for the two enzymes. The substantial downregulation by
an HDAC inhibitor of the demethylation reaction clearly points
to the fact that the two reactions/enzymes are coupled within
the CoREST complex, and it seems likely that there is some
form of structural coupling between the enzymes.
The coupling between the demethylation and deacetylation
reactions was further substantiated by using a doubly modified
substrate, K4meK9ac (Figure S4B). In this assay, the demethyla-
tion reaction is monitored at the same time as the deacetylation
reaction in real time using the NMR-based assay. The progres-
sion curves for K4meK9, K4K9ac, and K4meK9acwere analyzed
simultaneously with successively more complicated reaction
schemes (Table S6). The analyses and subsequent F tests
show that, with a very high confidence level, the two reactions
are coupled. Specifically, (1) the CoREST complex binds only
one substrate at once (p < 10100; model 2 versusmodel 4; Table
S6; Supplemental Information). Thus, the HDAC1 enzyme
cannot bind substrate when substrate is already bound to the
LSD1 enzyme and vice versa. (2) Both the demethylation and de-
acetylation reactions depend on the specific substrate (p <
10100; model 3 versus model 4). That is, the kinetic parameters
for deacetylation of K4meK9ac are different from those of
K4K9ac and the kinetic parameters for demethylation of K4me-
K9ac are different from those of K4meK9—consistent with
previous studies with isolated LSD1, which suggest that acetyla-
tion of K9 inhibits demethylation of K4 (Forneris et al., 2005). (3)
The CoREST complex exchanges between alternate states (p <
1030; model 4 versus models 8–10). The reaction scheme with
the most significant parameters, where proper convergence
could be obtained, is shown in Figure S4C.
Overall, the kinetic analyses of the two enzymes within the
CoREST complex reveal that they do not act independently
and that their activity andmodulation by inhibitors and activators
is closely coupled.Cell Reports 30, 2699–2711, February 25, 2020 2703
Structural Relationship between LSD1 and HDAC1
within the CoREST Complex
Given that there appears to be coupling between the enzymatic
activities of LSD1 and HDAC1 in the CoREST complex, we
sought to gain an understanding of the structural relationship
of the two enzymes in the complex. Attempts to obtain crystals
of the ternary complex were unsuccessful, suggesting that there
may be some flexibility within the complex that inhibits crystal
formation. In the absence of diffraction quality crystals, as a first
step, we used small angle X-ray scattering to analyze the overall
shape (‘‘envelope’’) of the CoREST complex. The small angle X-
ray scattering (SAXS) envelope of the CoREST complex has an
asymmetric bi-lobed architecture (Figures 3A and 3B). The crys-
tal structures of HDAC1:MTA1 (Millard et al., 2013; PDB: 4BKX)
and LSD1:RCOR1 (Forneris et al., 2007; PDB: 2V1D) could be
readily positioned within the SAXS envelope with the SWIRM
and AOD (amine oxidase domain) domains of LSD1 in one
lobe and LSD1(TOWER), RCOR1(LINKER-SANT2), and HDAC1:
MTA1(SANT1) in the other lobe. We used CORAL to refine the
position of the crystal structures and to model terminal regions
of the proteins as well as the RCOR1 linker so as to optimize
the fit with the SAXS data (Petoukhov et al., 2012). The theoret-
ical scattering curve calculated from this refined model of holo
CoREST complex gave a reasonable agreement with the exper-
imental data (Figure 3C). However, a Kratky plot of the SAXS
data suggests that the complex may have conformational flexi-
bility, limiting the quality of the fit (Figure 3D).
To test this model of the CoREST complex, we used cross-
linking analysis together with mass spectrometry to identify in-
teracting surfaces. The purified CoREST complex was cross-
linked by an isotopically coded NHS-activated ester cross-link-
ing reagent (Figure 3E). Liquid chromatography-mass spectrom-
etry (LC-MS) analysis identified cross-linked residues (Figure 3F).
Rather few cross-links that report on the relationship between
HDAC1 and LSD1 were identified. However, a cross-link be-
tween lysine 220 in HDAC1 with lysine 447 in the LSD1 TOWER
domain was particularly informative. This cross-link is clearly
compatible with the SAXS-derived model of the CoREST ternary
complex (Figure 3G).
Negative-stain electron microscopy was used to further inves-
tigate the architecture of the holo CoREST complex. Samples of
a lightly cross-linked CoREST complex were applied to a car-
bon-coated copper grid and stained with uranyl acetate (see
STAR Methods for details of sample preparation). The resulting
transmission electron microscopy (TEM) images revealed a ho-
mogeneous sample that enabled straightforwardmanual particle
picking in the EMAN2 software (Figure 4A). Two-dimensional
class averages generated using Relion revealed a clear two-
lobed complex joined by a linker (Figure 4B). This bi-lobed shape
fits well with the SAXS envelope. A 3D envelope for the structure
was generated using CryoSparc at an approximate resolution of
18 A˚ (Figures 4C and 4D). The coordinates for the known struc-
ture of the LSD1:RCOR1 complex and a model of the HDAC1:R-
COR1 complex (based on the HDAC1:MTA1 structure) could
readily be fitted into this envelope. In the resulting model, the
HDAC1 is located at the far end of the TOWER domain adjacent
to the SANT2 domain of RCOR1. In addition to the clearly
defined bridge between the two lobes, formed from the TOWER2704 Cell Reports 30, 2699–2711, February 25, 2020domain of LSD1 and the LINKER domain of RCOR1, there is ev-
idence of a second less substantial linker. This second linker can
be rationalized given that there must be a connection between
the C terminus of the RCOR-SANT1 domain and the N terminus
of the coiled coil LINKER domain of RCOR1 (Figure 4E). Howev-
er, due to the limited resolution, it is difficult to confidently orient
HDAC1 and its bound SANT1 domain within the lower lobe of the
structure. It is also likely that the SANT2 domain from RCOR1
may be repositioned somewhat, compared with the crystal
structure, to accommodate the HDAC1/RCOR1-SANT complex.
Given the homogeneity of the complex on negative-stain elec-
tron microscopy (EM) grids, we were hopeful to determine a
higher resolution structure using samples flash frozen in vitrified
ice (cryoelectron microscopy [cryo-EM]). A variety of different
EM grids were prepared using a range of different buffer and
cross-linking conditions. Cryo-EM data of the CoREST complex,
lightly cross-linked with glutaraldehyde, revealed once again a
clear bi-lobed structure in the 2D class averages (Figure S5C).
Calculation of a 3D model did not yield a structure with signifi-
cantly increased resolution but revealed a clearly asymmetric
bi-lobed envelope (Figure 4F). This allowed unambiguous fitting
of the LSD1:RCOR1 crystal structure. The remaining density
could accommodate the HDAC1:SANT in a similar position to
the model fitted in the envelope obtained from the negative stain
data.
We also collected cryo-EM data for the CoREST complex
cross-linked with BS3 using a Volta phase plate. The 2D class av-
erages from these micrographs were rather less homogeneous
(Figure S5D). Calculation of 3D models revealed two distinct
conformations for the CoREST complex (Figure 4G). The first
closely resembles the structure seen in both the negatively
stained dataset and the glutaraldehyde cross-linked dataset in
ice. In the second conformation, the HDAC1 is pivoted away
from the coiled coil of the LSD1 TOWER. We refer to these as
‘‘closed’’ and ‘‘open’’ conformations. Interestingly, in the BS3
cross-linked complex, in both frozen and negatively stained
complex, we observed some class averages in which the
HDAC1 was apparently fully detached from the LSD1 TOWER
and relocated toward the LSD1(AOD) domain (Figure S5E). We
believe that this is likely to be an artifact arising from partial
disassembly of the complex as a result of the harsh grid prepa-
ration process. Furthermore, in the absence of cross-linking, it
was only possible to observe isolated LSD1 on cryo-EM grids
(Figure S5E), emphasizing that the freezing process is damaging
to the integrity of the complex.
Structure of the CoREST Complex Bound to a Mono-
nucleosome
Although we have been unable to determine a high-resolution
structure of the CoREST complex, we sought to gain insights
into the interaction of the holo-complex with a mono-nucleosome
substrate.We took the strategyof preparing site-specificmodified
nucleosomes that contain a propargylamine mimic of histone H3
K4me2 (Culhane et al., 2006; Forneris et al., 2007). The nucleo-
some was assembled with 185-bp 601 DNA (Lowary and Widom,
1998), because it has been suggested that linker DNA is required
for tight binding between CoREST and nucleosomes (Kim et al.,
2015; Wu et al., 2018). This 185-bp H3K4-propargyl nucleosome
AC
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Figure 3. The CoREST Ternary Complex has a ‘‘Bi-lobe’’ Structure
(A) View of the SAXS envelope of theCoREST ternary complex fitted usingCORALwith the crystal structures of theMTA1:HDAC1 (PDB: 4BKX;Millard et al., 2013)
and LSD1:RCOR1 (PDB: 2V1D; Forneris et al., 2007) complexes. The linker and terminal disordered regions aremodeled and indicated by small C-alpha spheres.
(B) View as in (A) but rotated by 90.
(C) SAXS data for the CoREST ternary complex with the experimental scattering curve (blue) and theoretical scattering curve (red) from the LSD1:RCOR1:HDAC1
model. The residual errors of the fit are shown below the curve.
(D) A Kratky plot indicating that the CoREST complex is conformationally flexible.
(E) The CoREST ternary complex was cross-linked with increasing concentrations of CBDPSS.
(F) Schematic showing the CBDPSS cross-links identified in the CoREST ternary complex using mass spectrometry. Dotted lines indicated the cross-linked
residues with the xQuest ID score above 14.5.
(G) The SAXS-derivedmodel of the CoREST ternary complexwith cross-linked residues highlighted with dotted lines in pink. Black arrows indicate the active sites
of HDAC1 and LSD1.
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was designed to stabilize binding of the nucleosome to the FAD
(flavin adenine dinucleotide) at the LSD1 active site (Culhane
et al., 2006).
The complex between the 185-bp H3K4-propargyl nucleo-
somes and the holo CoREST complex was prepared at various
sample ratios (Figure 5A). The holo CoREST complex forms
both 1:1 and 2:1 bound complexes with the 185-bp H3K4-prop-
argyl nucleosomes. However, a percentage of unbound nucleo-
some was always observed, even on adding excess CoREST. In
order to reduce the heterogeneity of the sample, we performed a
further purification step through a 2.4 mL Superdex 200 column
(3.2/300). The fraction containing the largest proportion of CoR-
EST:nucleosome 1:1 complex was selected and cross-linked
with glutaraldehyde to make a sample for negative stain EM (Fig-
ure S7). Attempts to purify a CoREST:nucleosome 2:1 complex
were not successful due to too much heterogeneity.
The micrographs of the predominantly 1:1 complex gave rise to
rather heterogeneous 2Dclass averages. However, themajority of
particles fell into a limited number of highly populated classes (Fig-
ure 5B). These clearly contain the familiar bi-lobed particles of the
CoREST complex bound to a larger particle that resembles the
known structure of a nucleosome. Using these highly populated
class averages, it was possible to generate a 3D structural model
of the complex with a nominal resolution of 26 A˚ (Figures 5C and
5D). The bi-lobeddensity of theCoREST complex strongly resem-
bled the previous compact models observed in both the negative
stain and cryo-EM grids. We were readily able to dock the known
structures into the envelope (Figure 5E). It is clear that LSD1within
the CoREST complex is bound to the nucleosome (Luger et al.,
1997; PDB: 1AOI) in such a way that the H3K4-propargyl group
is able to engage with the active site of the LSD1 demethylase.
When LSD1 is engaged with the substrate, the HDAC1 is rather
far from the nucleosome and may not be able to target histone
tails in the same nucleosome. Interestingly, positively charged
residues in LSD1 are positioned such that they can mediate inter-
action with the phosphate backbone of the DNA around the dyad.
Furthermore, the positively charged region that has been previ-
ously found to interact with RNA is ideally positioned to interact
with the emerging linker DNA (Hirschi et al., 2016; Figures 5F
and 5G).
DISCUSSION
We have expressed and purified a stable ternary CoREST com-
plex in mammalian HEK293F cells. The complex is monomeric,
and both enzymes in the complex are active, demonstrating
that the complex is fully functional. In previous studies, weFigure 4. Structural Models of the CoREST Complex Generated Using
(A) Electron micrograph of negatively stained CoREST complex.
(B) Reference-free 2D class averages of the particles used to generate the 3D m
(C) Fourier shell correlation plot (CryoSparc). The resolution of the EM model wa
(D) Different views of the EM model of the CoREST complex (gray) fitted with the
shown in cyan, HDAC1 in salmon, and MTA1/RCOR1 in green.
(E) Schematic representation of the structural arrangement of the CoREST compl
S1, and S2, respectively.
(F) Refined 3D model of the glutaraldehyde cross-linked CoREST complex. The
(G) Two different structural models were generated for the BS3 cross-linked CoR
cross-linked complex, and an open form (21.5 A˚), in which the HDAC1 is pivotedhave used this complex to characterize a combined deacetylase
and demethylase inhibitor and to investigate specificity of the
complex for different modifications on a reconstituted nucleo-
some substrate (Kalin et al., 2018; Wu et al., 2018). In these
studies, we noticed that the demethylase activity did not appear
to follow Michaelis-Menten kinetics and therefore established a
simultaneous, real-time demethylase and deacetylase assay.
Using this approach, we have shown that the two enzymeswithin
the CoREST complex, HDAC1 and LSD1, are coupled andmutu-
ally influence the activity of the other enzyme. Consistent with
this, we showed that inhibitors and activators of one enzyme
also influence the activity of the other enzyme. Indeed, the ef-
fects of InsP6 are greater on the demethylase than the deacety-
lase reaction. Furthermore, we have found that both enzymes
exist in at least two distinguishable states that differ in their ki-
netic properties. It is likely that this reflects two structurally
distinct states of the complex. We also observed that the com-
plex can only engage with one substrate at a time. However, a
limitation of this study is that isolated peptides were used for
the 1H NMR-based assays rather than nucleosomes, because
nucleosomes will impose spatial restraints that could influence
the accessibility of the H3 tails.
To date, there have been no structural studies of the CoREST
ternary complex. However, there have been numerous crystallo-
graphic studies of the LSD1:RCOR1 complex as well as
modeling to predict the mode of interaction with nucleosomes
(Baron et al., 2011; Baron and Vellore, 2012a, 2012b; Forneris
et al., 2007; Pilotto et al., 2015; Yang et al., 2007, 2006). Although
there is no structure of HDAC1 in complex with RCOR1, the
structure of HDAC1:MTA1 complex (Millard et al., 2013; Watson
et al., 2016) enables us to model the HDAC1:RCOR1 complex.
To investigate the physical relationship between the HDAC1
and LSD1 in the ternary complex, we have used SAXS, cross-
linking-MS, negative-stain EM, and cryo-EM. The results from
these complementary approaches are consistent with each
other and reveal a bi-lobed structure with the LSD1 demethylase
at one end and the HDAC1 at the other. The known
LSD1:RCOR1 and HDAC1 structures fit well within the SAXS
and EM envelopes. The orientation of the LSD1 is relatively
well defined by the distinctive tower domain. In contrast, the
orientation of the HDAC1 is less well defined and the calculated
best fit to each of the EM envelopes is somewhat variable. In all
the structures, HDAC1 is positioned close to the SANT2 domain
of RCOR1 and likely makes a direct interaction with this domain.
Previous models of the LSD1:RCOR1 in complex with a nucleo-
some have suggested that the SANT2 domain might bind to the
outer surface of the DNA wrapped around the nucleosomeNegative Stain and Cryo-electron Microscopy
odel.
s approximately 18 A˚.
crystal structures of the MTA1:HDAC1 and LSD1:RCOR1 complexes. LSD1 is
ex. RCOR1 is green. The ELM2, SANT1, and SANT2 domains are indicated E2,
estimated resolution is 17.5 A˚ (Relion).
EST complex: a closed form (20 A˚), which closely matches the glutaraldehyde
away from the LSD1 tower domain.
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Figure 5. Structural Model of the CoREST
Complex Bound to Semi-synthetic H3K4-
Propargyl-Modified Nucleosome (Nega-
tive-Stain EM)
(A) Electrophoretic mobility shift assay (EMSA)
assay of the CoREST complex (labeled LHC)
binding to 185-bp H3K4-propargyl nucleosome.
(B) Reference-free 2D class averages of the par-
ticles used to generate the 3D model.
(C) Fourier shell correlation plot (Relion3.0). The
resolution of the EM model was approximately
26 A˚.
(D) 3D envelope of the CoREST complex bound to
the nucleosome.
(E) Crystal structures of the nucleosome, HDAC1,
LSD1, and RCOR1 fitted into the EMenvelope. H3,
blue; H4, dark green; H2A, yellow; H2B, red (PDB:
1AOI; Luger et al., 1997).
(F and G) Orthogonal views of the charged surface
of the LSD1:RCOR positioned as seen in the EM
structure of the CoREST complex bound to a
nucleosome. The binding surface for RNA (nucleic
acid) is highlighted as is the LSD1 active site with
the H3 peptide (1–16 aas) shown in purple (PDB:
2V1D, Forneris et al., 2007; PDB: 4XBF, Hirschi
et al., 2016).(Pilotto et al., 2015; Yang et al., 2006). This has led to the concept
of a nanoscale clamp positioning the LSD1:RCOR1 around the
nucleosome (Baron and Vellore, 2012a, 2012b). The position of
HDAC1 we observe in the ternary complex shows that it is in
close proximity to the SANT2 domain. This suggests that it is un-
likely that the ternary complex would be able to interact with a
nucleosome in the way that has been predicted.
It is interesting that, in theBS3 cross-linked cryo-EMsample,we
observe a second (less populated) form of the complex. In this
complex, the HDAC1 appears to be rotated away from the LSD1
TOWER domain. Although it is not possible to rule out that this is
an artifact of the grid preparation and flash freezing, it may reflect
an alternative formof the complex. It certainly seems likely that the
alternative state of the complex revealed from the enzyme kinetics
results from some structural change in the complex. Interestingly,
molecular dynamics analyses of the LSD1:RCOR1 complex have
suggested that the SANT2 domain may rotate and swing with2708 Cell Reports 30, 2699–2711, February 25, 2020respect to the TOWER of LSD1 (Baron
and Vellore, 2012a, 2012b). This is consis-
tentwith themotion thatwould be required
to create the alternative conformation un-
der the BS3 cross-linking conditions.
Given that that the structure we
observe for the ternary CoREST complex
appears inconsistent with previous
models of how LSD1:RCOR1 binds nu-
cleosomes, we wished to investigate
how the ternary CoREST complex inter-
acts with a mono-nucleosome using
negative-stain EM. To aid formation of a
stable complex, we prepared a modified
nucleosome in which H3K4 was replacedwith a propargylamine group that can form a non-reversible
coupling with the FAD co-factor in the active site of LSD1. We
reasoned that the resulting complex would provide an experi-
mental understanding of how LSD1, in the context of the ternary
CoREST complex, targets methylated K4 in a chromatin
substrate.
Although the 2D class averages revealed some heterogeneity
in the complex, a dominant proportion of particles were grouped
intoa small consistent set of class averages, inwhich thebi-lobed
CoREST complex was clearly docked with the edge of the nucle-
osome disk. The HDAC1 is rather distant from the nucleosome
and unlikely to be able to interact with histone tails from the
same nucleosome. It may be possible for HDAC1 to target an
adjacent nucleosome; however, the enzymology suggests that
only one substrate can be engaged at a time. The LSD1 is posi-
tioned such that a relatively basic surface of the demethylase
domain of LSD1 (but not the SWIRM domain) interacts with the
nucleosomal DNA close to the dyad of the nucleosome, where
the linker DNA enters and leaves the nucleosome. The H3K4-
propargyl in the histone tail can readily reach the active site of
LSD1. Intriguingly, the region of LSD1 that has previously been
shown to interact with RNA (Hirschi et al., 2016) is positioned
very close to where the linker DNA would likely interact with the
LSD1 demethylase domain. It is not clear what the implications
of this might be. However, two studies have shown that CoREST
preferentially binds nucleosomes with longer linker DNA (Kim et
al., 2015; Wu et al., 2018). This finding prompted us to use
185-bp DNA in this structure. Unfortunately, the linker DNA is
not visible at this resolution, and a more detailed understanding
of this will require a higher resolution structure.
In conclusion, our investigation into the CoREST ternary com-
plex has revealed a molecular machine in which the two en-
zymes, deacetylase and demethylase, are functionally and
structurally coupled.STAR+METHODS
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Chemicals, Peptides, and Recombinant Proteins
Polyethylenimine (PEI) Sigma-Aldrich CAT# 408727
Anti-Flag M2 affinity gel Sigma-Aldrich CAT# A2220
Rink Amide SpheriTide resin (1.05 mmol/g substitution) CEM CAT# R002-A
Fmoc-Ala-OH Novabiochem CAT# 852003 CAS# 35661-39-3
Fmoc-Arg(Pbf)-OH Novabiochem CAT# 852067 CAS# 154445-77-9
Fmoc-Thr(tBu)-OH Novabiochem CAT# 852000 CAS# 71989-35-0
Fmoc-Lys(Me,Boc)-OH Novabiochem CAT# 852106 CAS# 951695-85-5
Fmoc-Gln(Trt)-OH Novabiochem CAT# 852045 CAS# 132327-80-1
Fmoc-Lys(Boc)-OH Novabiochem CAT# 852012 CAS# 71989-26-9
Fmoc-Ser(tBu)OH Novabiochem CAT# 852019 CAS# 71989-33-8
Fmoc-Gly-OH Novabiochem CAT# 852001 CAS# 29022-11-5
Fmoc-Pro-OH Novabiochem CAT# 852017 CAS# 71989-31-6
Fmoc-Leu-OH Novabiochem CAT# 852011 CAS# 35661-60-0
Fmoc-Lys(Ac)-OH Novabiochem CAT# 852042 CAS# 159766-56-0
N,N-dimethylformaldehyde (DMF) Rathburn Chemicals CAT# PTS6020 CAS# 68-12-2
1-Methyl 2-pyrrolidone (NMP) Rathburn Chemicals CAT# PTS6035 CAS# 872-50-4
Piperidine Sigma-Aldrich CAT# 104094 CAS# 110-89-4
O-(1H-6-Chlorobenzotriazole-1-yl)-1,1,3,3-
tetramethyluronium hexafluorophosphate (HCTU)
Novabiochem CAT# 851012 CAS# 330645-87-9
OxymaPure Novabiochem CAT# 8.51086 CAS# 3849-21-6
Diisopropylethylamine (DIPEA) Sigma-Aldrich CAT# D125806 CAS# 7087-68-5
Trifluoroacetic acid (TFA) Sigma-Aldrich CAT# T6508 CAS# 76-05-1
Triethylsilane (TES) Sigma-Aldrich CAT# 230197 CAS# 617-86-7
Fmoc-Gln(Trt)-Thr(cMe,Mepro)-OH Novabiochem CAT# 8.52198 CAS# 1572725-72-4
Fmoc-Ser(tBu)-Thr(cMe,Mepro)-OH Novabiochem CAT# 8.52192CAS# 1266350-99-5
MS-275 (Entinostat, SNDX-275) Sigma-Aldrich CAT# EPS002 CAS# 209783-80-2
TSA (Trichostatin A) Sigma-Aldrich CAT# T8552 CAS# 58880-19-6
SAHA (Vorinostat) Sigma-Aldrich CAT# SML0061 CAS# 149647-78-9
2-PCPA (trans-2-Phenylcyclopropylamine hydrochloride) Sigma-Aldrich CAT# P8511 CAS# 1986-47-6
InsP4 (D-myo-Inositol-1,4,5,6-tetraphosphate) Cayman Chemical CAT# 10007783 CAS# 157542-47-7
InsP5 (D-myo-Inositol-1,3,4,5,6-pentaphosphate) Cayman Chemical CAT# 10007784
InsP6 (Phytic Acid) Sigma-Aldrich CAT# 68388 CAS# 14306-25-3
Boc-Lys(ac)-AMC BaChem CAT# 4033972
Horseradish peroxidase (HRP), EIA grade ThermoFisher Scientific CAT# 012001
Amplex Red Reagent ThermoFisher Scientific CAT# A22177
CBDPSS Creative Molecules Inc. CAT# 014SS
Glutaraldehyde Sigma-Aldrich CAT# G5882 CAS# 111-20-8
BS3 (Sulfo-DSS) Crosslinker ThermoFisher Scientific CAT# A39266
2-(Methylamino)ethanol Sigma-Aldrich CAT# 471445 CAS# 109-83-1
Propargyl bromide Sigma-Aldrich CAT# 81831 CAS# 106-96-7
Histone proteins (Wu et al., 2018) N/A
H3K4me 1-21 peptide This paper N/A
H3K9ac 1-21 peptide This paper N/A
H3K4meK9ac 1-21 peptide This paper N/A
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Deposited Data
Negative stain map: CoREST complex EMDB EMDB: EMD-10626
Cryo-EM map: Glutaraldehyde crosslinked complex EMDB EMDB: EMD-10627
Cryo-EM map: BS3 crosslinked complex-closed form EMDB EMDB: EMD-10628
Cryo-EM map: BS3 crosslinked complex-open form EMDB EMDB: EMD-10629
Negative stain map: CoREST-nucleosome complex EMDB EMDB: EMD-10630
SAXS data SASDB SASDB: SASDH45
Experimental Models: Cell Lines
FreeStyle 293-F cells ThermoFisher Scientific CAT# R79007
Oligonucleotides
50 Primer for cloning CoREST (aa 86) protein into
pLEICS12 vector: GTATTTTCAGGGCGCCATGTG
GGAGGAAGGCAGC
Eurofins Genomics N/A
30 Primer for cloning CoREST protein (aa 485) into
pLEICS12 vector: GACGGAGCTCGAATTTCAGG
AGGCAGATGCATATCT
Eurofins Genomics N/A
50 Primer for cloning LSD1 protein (aa 1) into
pLEICS12 vector: ACCCAAGCTTGGTACCATGTT
ATCTGGGAAGAAGGCG
Eurofins Genomics N/A
30 Primer for cloning LSD1 protein (aa 852) into
pLEICS12 vector: GACGGAGCTCGAATTTCACA
TGCTTGGGGACTGCTGTGC
Eurofins Genomics N/A
50 Primer for the mutagenesis of H3(K4C):
CTCGTACTTGTCAGACCGCCCGCAAG
IDT N/A
30 Primer for the mutagenesis of H3(K4C):
GGCGGTCTGACAAGTACGAGCCATATG
IDT N/A
185 bp 601 DNA (Wu et al., 2018) N/A
Recombinant DNA
IMAGE clone: CoREST Source BioScience ID: 40080558
IMAGE clone: LSD1 Source BioScience ID: 5298150
Plasmid: pLEICS12-(His)10(Flag)3-CoREST(aa 86-485) This paper N/A
Plasmid: pLEICS12-LSD1 (full length) This paper N/A
Plasmid: pLEICS12-HDAC1 (full length) (Millard et al., 2013) N/A
Software and Algorithms
Prism (version 7.0) GraphPad https://www.graphpad.com/
scientific-software/prism/
NMRPipe (Delaglio et al., 1995) https://www.ibbr.umd.edu/
nmrpipe/install.html
FuDA (Hansen et al., 2007) https://www.ucl.ac.uk/hansen-lab/
NMR data fitting algorithms This paper https://www.ucl.ac.uk/hansen-lab/
ScA˚tter (Hura et al., 2009) http://www.bioisis.net;
https://bl1231.als.lbl.gov/scatter
SAXS MoW (Piiadov et al., 2019) http://saxs.ifsc.usp.br/
CORAL (Petoukhov et al., 2012) https://www.embl-hamburg.de/
biosaxs/atsas-online/coral.php
CRYSOL (Svergun et al., 1995) https://www.embl-hamburg.de/
biosaxs/atsas-online/crysol.php
xQuest (Leitner et al., 2014) http://prottools.ethz.ch/orinner/
public/htdocs/xquest/
EMAN2 (Tang et al., 2007) https://blake.bcm.edu/
emanwiki/EMAN2
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SPHIRE-crYOLO (Wagner et al., 2019) http://sphire.mpg.de/wiki/doku.php?id=
pipeline:window:cryolo
Relion2 (Scheres, 2012) https://www3.mrc-lmb.cam.ac.uk/
relion/index.php/Main_Page
Relion3.0 (Zivanov et al., 2018)
CryoSparc (Punjani et al., 2017) https://cryosparc.com/
Pymol (Version 1.8) Schro¨dinger, LLC https://pymol.org/2/
Chimera (Version 1.13.1) (Pettersen et al., 2004) https://www.cgl.ucsf.edu/chimera/LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, John
Schwabe (john.schwabe@le.ac.uk).
All unique reagents generated in this study are available from the lead contact with a completed Materials Transfer Agreement.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mammalian Protein Expression
The CoREST ternary complex was comprised of full length LSD1 (UniProt ID: O60341), full length HDAC1 (UniProt ID: Q13547) and
N-terminally truncated RCOR1 (86-485aa) (UniProt ID: Q9UKL0). The pcDNA3 vector was used to create plasmids encoding the
different proteins. The RCOR1 constructs contained an N-terminal (His)10(Flag)3 tag followed by a Tev protease cleavage site.
The constructs for ternary complex were co-transfected into suspension-grow HEK293F cells (ThermoFisher Scientific) with polye-
thylenimine (PEI) (Sigma) and harvested after 48 hours as described previously (Kalin et al., 2018; Wu et al., 2018).
METHOD DETAILS
Mammalian Protein Purification
Cells were lysed in buffer containing 50 mM Tris/Cl pH 7.5, 50 mM potassium acetate, 5% v/v glycerol, 0.4% v/v Triton X-100, and
Roche Complete Protease Inhibitor (buffer A). Insoluble materials were removed by centrifugation. The complex was purified on Flag
resin (Anti-Flag M2 affinity gel, Sigma). The resin was washed once with buffer A, three times with buffer B (50 mM Tris/Cl pH 7.5,
50 mM potassium acetate, and 5% v/v glycerol), and three times with buffer C (50 mM Tris pH 7.5, 50 mM potassium acetate,
5% v/v glycerol and 0.5 mM TCEP) followed by an overnight TEV protease cleavage in buffer C. The complex was further purified
by gel filtration chromatography on a Superose 6 column (GE Healthcare) in buffer containing 25 mM Tris pH 7.5, 50 mM potassium
acetate, and 0.5 mM TCEP.
Size-Exclusion Chromatography with Multi-Angle Light Scattering (SEC-MALS)
Purified CoREST ternary complex that has been gel filtrated was concentrated to > 1 mg/ml. The complex was reapplied to a Super-
ose 6 column. The mass of the complex was detected on elution with an 18-angle MALS light scattering detector (DawnHELEOS
II) coupled with a differential Refractive Index detector (Optilab T-rEX) (Wyatt Technology).
Boc-Lys(Ac)-AMC HDAC Assay
HDAC activity of the CoREST complex was measured using a fluorescent-based HDAC assay with Boc-Lys(Ac)-AMC substrate.
25 nM of purified complex, and 500 mM of substrate were used in a final volume of 50 ml in assay buffer (50 mM Tris pH 7.5,
50 mM NaCl, 0.1 mg/ml BSA). Inositol phosphates (100 mM) and HDAC inhibitors (5 mM) were tested for their ability to activate or
repress the complex by pre-incubating with the complex in varying concentrations at 37C for 30 minutes before adding the sub-
strate. The assay was developed by the addition of 50 ml of developer solution (2 mM TSA, 10 mg/ml Trypsin, 50 mM Tris pH 7.5,
100 mM NaCl). Fluorescence was measured at 335/460 nm using a Victor X5 plate reader (Perkin Elmer). Data analyzed using
GraphPad Prism (version 7.0, GraphPad Software, Inc.).
Horse Radish Peroxide (HRP)-coupled Demethylase Assay
The Demethylase assay was performed using an Amplex UltraRed reagent (Thermo Fisher Scientific) which fluoresces on a per-mole
basis in a HRP-coupled assay (Zhu et al., 2010). A final concentration of 50 nM CoREST complex was used in a reaction volume of
100 ml. For LSD1 inhibition by LSD1 inhibitors, the protein sample was pre-incubated with the inhibitors for half hour in assay buffer
containing 20 mM HEPES pH 7.5 and 50 mM NaCl at room temperature. Amplex UltraRed reagent (10 mM) and HRP (0.04 mg/ml)e3 Cell Reports 30, 2699–2711.e1–e8, February 25, 2020
were added before the assay was initiated with 15 mM of H3K4me peptide substrate. Fluorescence was measured at 530/590 nm
using a Victor X5 plate reader (Perkin Elmer) after 30minutes. All measurements were performed in triplicate and data analyzed using
GraphPad Prism.
Peptide synthesis for NMR based enzymatic assay
The peptides were synthesized on a Biotage Initiator+ Alstra machine on Rink Amide SpheriTide resin (1.05 mmol/g substitution,
CEM). Fmoc-protected amino acids weremade up as a solution of 0.2M in DMF to give 5 equivalents relative to the resin once added
to the reaction vessel. The activator was made up to 0.5 M HCTU in DMF and the activator base was made up to 2 M DIPEA in NMP.
These solutions allowed for 5 equivalents of activator and 10 equivalents of activator base relative to the resin. Deprotection solution
wasmade up to 20% v/v piperidine in DMF solution with 0.1MOxymaPure. Double coupling of Fmoc-Arg(Pbf)-OH was carried out at
room temperature for 25 mins, then heated to 75C for 5 mins, drained and a second coupling step carried out at 75C for 5 mins. All
other amino acids were coupled at 75C for 5 mins. Deprotections were carried out at 75C for 30 s, followed by a second depro-
tection at 75C for 3 mins. Pseudoproline residues were used to help prevent the formation of on-resin secondary structures.
Fmoc-Gln(Trt)-Thr(cMe,Mepro)-OH for Gln5-Thr6 and Fmoc-Ser(tBu)-Thr(cMe,Mepro)-OH for Ser11-Thr12.
Synthesized peptides were cleaved from the resin using a cleavage cocktail of TFA/TES/water (95:2.5:2.5) for 3 hours before being
drained and the TFA blown off with a stream of nitrogen. The peptide was precipitated and washed three times in cold diethyl ether
and spun down to a pellet before the diethyl ether removed and the peptide dried under a steady stream of nitrogen.
Crude peptides were purified by reverse-phase HPLC using a Dionex Ultimate 3000 system with a Phenomenex Gemini-NX 5 mm
C18 110 A˚ AXIA packed column with dimensions 250 3 21.20 mm and purity confirmed by analytical reverse-phase HPLC using a
Dionex Ultimate 3000 system with a Phenomenex Aeris 5 mm Peptide XB-C18 100 A˚ packed column with dimensions of 150 3
4.6 mm. LC-MSwere run using a Xevo QTof mass spectrometer (Waters) coupled to an Acquity LC system (Waters) using an Acquity
UPLCBEHC18 column (2.13 50mm,Waters). The flow rate was 0.6mLmin-1 and the gradient was as follows: 95%Solvent A (0.1%
formic acid in water) with 5% solvent B (0.1% formic acid in acetonitrile) was held constant for 0.5min, followed by a linear gradient to
100% B over the next 2.1 min. After 1 min at 100% solvent B, the gradient was returned to 95% solvent A and 5% solvent B over
0.2 min. The ESI capillary voltage was 3 kV, cone voltage 30 V and collision energy 4 eV. The MS acquisition rate was 10 spectra
per second and m/z data ranging from 50 to 2000 Da was collected. Mass accuracy was achieved using a reference lock mass
scan, once every 10 s. Water was removed by lyophilisation using a FreeZone Benchtop Freeze Dry System. The purity of the pep-
tides used in the biological assays were determined to be greater than 95% in all instances.
1D-NMR based Real-time Enzymatic Assay
NMR sample preparation
TheCoREST ternary complex was purified and used in this assay. The protein was gel filtrated in buffer containing 10mMTris pH 7.5,
50 mM KCl and 0.5 mM TCEP. Substrate peptides were dissolved in the same buffer as the gel filtration buffer.
NMR experiments
Substrate peptide sampleswereprepared to yield a final concentration in a range from50mMto800 mM (final volumeof 600 ml, in a 5mm
WilmadNMR tube) with 5% D2O. A reference 1H 1D spectrum was recorded using excitation sculpting water suppression, 4 dummy
scans, 16 scans, a recovery delay of 1 s and an acquisition time of 2.04 s, leading to a total acquisition time of 61 s. 16k complex points
were recordedwitha sweepwidthof 8012Hz. Proteinwas added tostart the enzymatic reactionwith a final concentrationof 50– 200nM
inafinal volumeof600ml. Inhibitorswerepre-incubatedwith thecomplex for 30minutes.One roundofgradient shimmingwasperformed
followed by the acquisition of a series of 1D 1H NMR spectra with the same parameters as the reference spectrum. The time between
the addition of the CoREST complex and the acquisition of the first 1D 1H NMR experiment was started was approximately 80 s and
this ‘deadtime’ was noted for each time series. 1D-NMR spectra were recorded on a Bruker Avance 500 over a certain time course.
Analysis of NMR spectra
The NMR spectra were processed using NMRPipe (Delaglio et al., 1995), using a 1.8 Hz exponential line broadening prior to Fourier
transformation. A polynomial baseline correction as implemented in NMRPipe was applied after the Fourier transform. All 1D 1H NMR
spectrawithin a time series were collected into a pseudo 2D spectrum. Signal intensitieswere determined using the programFuDA as
described previously (Hansen et al., 2007) by fitting a mixed Gaussian/ Lorentzian line shape to each peak and assuming a common
line shape for a given peak during a time series (i.e., line shape and peak positions are independent of time). Subsequently the peak
intensities were converted to concentrations (in mM) by using a reference sample with known concentration.
Data analysis of NMR based enzymatic assay
Least-squares fitting of kinetic parameters: A program was written in C++ to analyze the obtained substrate concentrations versus
time and to extract kinetic parameters and standard errors. In the program the ordinary differential equations that describe the ki-
netics were integrated numerically over the time domain using a controlled adaptive Runge-Kutta Cash-Karp (Bader and Deuflhard,
1983; Abramowitz and Stegun, 1965) stepper in the odeint function implemented in the C++ boost class library (https://www.boost.
org). Thus, for each set of rate constants, {kj}j, and initial substrate concentrations [S]0,i, the progression curves originating for
different initial substrate concentration but same rates constants, [S]calc(t; S0,i, kj) were calculated.Cell Reports 30, 2699–2711.e1–e8, February 25, 2020 e4
Best-fit parameters were obtained using a Levenberg-Marquardt least-squares fitting algorithm similar to that described by Press
et al. (1992). The model fitting parameters included the initial concentrations of the substrate and the micro-kinetic rate constants,
expect for the second-order substrate-enzyme association rate, k1. Specifically, the c
2 that was minimized in the fit was defined as
c2ðt;S0;i; kjÞ =
X
i;k

½Scalcðtk;S0;i; kjÞ  ½Si;expðtkÞ
2
s2
where the sum over i is the experiments with different initial substrate concentration and the sum over k is the different time points,
where the substrate concentration was observed experimentally. The uncertainty s was set to 1 mM for all points as judged from the
signal-to-noise. The derivatives d[S]calc/dS0,i and d[S]calc/dkj used to generate the Jacobi matrix for the least-squares fit were ob-
tained numerically and only elements of the Jacobi matrix that were know a priori to be non-zero were calculated.
Extensive grid searches were performed initially to obtain good starting parameters for the fit. Standard errors of the obtained
model parameters were determined from the co-variance matrix (Press et al., 1992) or by a bootstrap approach (500 runs) (Efron
and Tibshirani, 1986). Each least-squares fit of the singly modified substrates K4MeK9 and K4K9Ac took approximately 15 min
on a desktop computer with sixteen 3.2 GHz processors. Significance p-levels were calculated using F-tests and the incomplete
beta-function. The program and source codes are available from the authors upon request.
Considerations made in regards to the least-squared analysis: It was assumed that the second order association rate constant
between E and S and between E* and S are identical and equals k1. Initial analyses, grid searches, and chi-square analyses showed
that the data does not contain sufficient information for an accurate value of k1 to be determined, yet k1 is close to the diffusion limit. In
all the analyses it was therefore assumed that k1 = 200,000 s
-1M-1. Larger values for k1 increased the time for solving the coupled
differential equations, however it did not improve the chi-square, while smaller values slightly increased the obtained chi-square, c2.
The reaction scheme in Figure 3 is circular between the four species E, ES, E*S and E*. Therefore, although there are eight rate
constants between E, E*, ES and E*S, there are only seven independent rates if the system is to be thermodynamically stable. In
the analysis, the value for the disassociation of E*S was chosen to be calculated from the other rate constants:
k1 =
kES
kES
kE
kE
k1 =
KeqðEÞ
KeqðESÞk1
Expression for reaction rates at short times: As discussed in themain text, since kE + k-E, kES + k-ES kcat,E, k-1 two limiting cases are
considered. For short times, t 1/(kE+k-E), 1/(kES+k-ES) the two forms of the enzyme E and E* present at the start of the reaction are
effectively converting the substrate independently. It is assumed that the equilibrium between E and E* has been reached by the start
of the experiment and it not perturbed initially, thus the population of E, pE, immediately before adding substrate is given by,
KeqðEÞ + 1= ½E

½E +
½E
½E=
1
pE
The overall rate is given by
v0 =  dS
dt
= ½ESkcat;E + ½ESkcat;E
Assuming steady state for both ES and E*S, that is, d[ES]/dt = 0 and d[E*S]/dt = 0 gives:
v0 =
E0
1+KeqðEÞ
kcat;E + kcat;EKeqðEÞ
1+KM;E
½S+KM;E
½S+KM;EKM;E
.
½S2
where
KM;E =
kcat;E + k1
k1
KM;E =
kcat;E + k1KeqðEÞ

KeqðESÞ
k1
It is noted that for short times the initial rate v0 cannot be cast in a form of apparent Michaelis-Menten parameters. Still, when the
kinetic parameters and initial substrate concentration are known, the limiting initial rate can be calculated using the equation above
as shown in Figure 2 (dotted lines).
Expression for apparent Michaelis–Menten parameters for long times: For times t[ 1/(kE+k-E), 1/(kES+k-ES) an equilibrium be-
tween E, E*, ES and E*S is reached and apparent Michaelis-Menten parameters can be calculated. Since equilibrium is assumed
to have been reached:
Keq Eð Þ= E
½ 
E½  and Keq ESð Þ=
ES½ 
ES½ e5 Cell Reports 30, 2699–2711.e1–e8, February 25, 2020
The total enzyme concentration, [E]0, is given by:
E½ 0 = E½ + ES½ + E½ + ES½  0½E = ½E0  ½ESð1+KeqðESÞÞ
1+KeqðEÞ
and assuming steady state for ES and E*S gives:
v0 =
kcat;E E½ 0 1+Keq ESð Þ kcat;Ekcat;E
 
1+Keq ESð Þ+ 1+Keq Eð Þð Þ KM;ES½ 
where the apparent Michaelis-Menten parameters are:
KM;app = KM;E
1+KeqðEÞ
1+KeqðESÞkcat;app = kcat;E
1+Keq ESð Þ kcat;Ekcat;E
1+Keq ESð Þ
It should be noted that these apparent parameters are only valid after equilibrium has fully been reached (dashed lines in Figure 2).
Small-Angle Light Scattering (SAXS)
Purified CoREST ternary complex was concentrated to 1 mg/ml before analysis. Data were collected at Diamond Light Source small
angle scattering B21 beam line (Didcot, Oxford, UK). The datasets were analyzed using ScA˚tter (Hura et al., 2009). A structural model
based on the crystal structure of crystal structures of HDAC1:MTA1 (PDB: 4BKX) and LSD1:RCOR1 (PDB: 2V1D) was calculated us-
ing CORAL (Petoukhov et al., 2012). The comparisons of theoretical scattering curves and the experimental datasets were performed
using CRYSOL (Svergun et al., 1995). Data collection and analysis details are described in supplementary material Table S7.
Chemical cross-linking mass spectrometry
Isotopically-coded NHS-activated ester cross-linker CBDPSS was used to cross-link the protein sample. Purified CoREST complex
was buffer exchanged into cross-linking buffer (50 mM HEPES and 50 mM potassium acetate) and then concentrated to 1 mg/ml.
Protein was mixed with 0.2-10 mM of CBDPSS in a v/v ratio of 1:1. Reaction was performed at room temperature for 1 hour and
stopped with a final concentration of 40 mM (NH4)2CO3. Cross-linked sample were analyzed by SDS-PAGE. The gel bands corre-
sponding to the cross-linked complex were cut and analyzed by LC-MS. Cross-linked peptides were identified using the xQuest
(Leitner et al., 2014).
Histone expression and purification
The full-length Xenopus histones (H2A, H2B, H3(K4C) or H4) in a pET expression vector were expressed in BL21(DE3)pLysS E. coli
and induced with IPTG (0.2 mM) at 37C for 3 h. Cells were pelleted and resuspended with histone wash buffer (50 mM Tris pH 7.5,
100 mM NaCl, 1 mM EDTA and 1% Triton X-100) followed by lysed with French press. The inclusion bodies were pelleted, washed
with histone wash buffer without Triton X-100, and then resuspended in histone unfolding buffer (6 M guanidinium chloride, 20 mM
Tris pH 7.5 and 10mMDTT) and then buffer exchanged into IEX buffer (7M urea, 10mMTris pH 7.8, 1mMEDTA and 5mMBME). The
histone was purified by tandem HiTrap Q-SP columns with a NaCl gradient from 0 mM to 500 mM with IEX buffer. After dialysis
against water, histone proteins were lyophilized to dryness.
Preparation of propargylamine-containing mimic of dimethyl Lys4 histone H3
The histone H3 (K4C) protein was dissolved in reaction buffer (4 M guanidinium chloride, 1 M HEPES pH 7.8, 10 mM L-Met), and DTT
was added to a final concentration of 10mM. Themixture was heated at 37C for 1 h and diluted 4-fold with the reaction buffer. Next,
1-methyl-1-(prop-2-ynyl)aziridinium chloride was added to a final concentration of 15 mM in an ice bath. The mixture was kept at
25C for 20 h. The reaction was monitored by mass spectrometry and the product was purified by reversed phase HPLC with a
C4 column.
Histone octamer refolding and nucleosome reconstitution
The core histone proteins H2A, H2B, H3(K4C) and H4 were dissolved in unfolding buffer (7 M guanidine, 20 mM Tris pH 7.5 and
10 mM DTT) and dialyzed against high salt buffer (20 mM Tris pH 7.5, 2.0 M NaCl, 1 mM EDTA and 5 mM BME). The octamerCell Reports 30, 2699–2711.e1–e8, February 25, 2020 e6
was purified by size exclusion chromatographywith a Superdex 200 column. The 185 bp 601DNAwas amplified by PCR from the 601
DNA template and purified by anion exchange chromatography with a TSKgel column.
The histone octamer and DNA were mixed at a 1:1 molar ratio in high salt buffer (10 mM Tris 7.5, 2.0 M KCl, 1 mM EDTA and 1 mM
DTT), and themixture was gradually dialyzed to low salt buffer (10 mM Tris pH 7.5, 0.25MKCl, 1 mMEDTA and 1mMDTT) over 36 h.
The nucleosomes were purified by anion exchange chromatography with TSKgel and dialyzed to 20 mM Tris pH 7.5 and 1 mM DTT.
Due to the zinc ion in the CoREST complex, we did not add 1 mM EDTA to the nucleosome storage buffer.
Structural determination of the CoREST complex using negative stain EM
The CoREST ternary complex was purified through a Superose 6 column and the peak fraction was concentrated and further purified
in a 5%–25% sucrose density gradient (with 0%–0.1% glutaraldehyde). The sucrose density gradient was made in buffer containing
20 mM HEPES pH 7.5 and 40 mM NaCl. The gradient was manually fractionated with a fraction volume of 175 ml. The fraction con-
taining intra-complex cross-linked sample was selected and buffer exchanged into 25mMTris pH 7.5, 50mMpotassium acetate and
0.5 mM TCEP.
Negative-stain grids (carbon film 400 mesh copper grid, Agar Scientific) were prepared by glow-discharging in an auto sputter
coater (E5200, Quorum Technologies) for 30 s at 10 mA. 50 ng of the CoREST ternary complex was applied onto the grid and the
excess liquid was blotted after 1-minute incubation. 2% uranyl acetate was used to stain the sample. The grid was visualized on
a JEOL 2010F 200kV electron microscope and micrographs were taken using a Gatan Ultrascan 4000 camera at University of War-
wick. 364 micrographs were collected with defocus values of0.5 mm,1.0 mm,1.5 mm, and2.0 mm. EMAN2 (Tang et al., 2007),
Relion2.1 (Scheres, 2012) and Cryosparc (Punjani et al., 2017) were used for data analysis.
Structural determination of the CoREST complex bound to synthetic site-specific nucleosome using negative stain EM
The CoREST complex was purified through Superose 6 column in buffer containing 20 mM HEPES and 50 mM NaCl. A propargyl-
amine-containingmimic of dimethyl Lys4 histone H3was prepared as previously described (Pilotto et al., 2015). Themodified histone
H3 and E. coli ExpressedH2A, H2B andH4were then assembledwith 185 bp 601 nucleosomal DNA as previously reported (Wu et al.,
2018). Interactions of the nucleosome with the CoREST complex were analyzed on a 0.7% agarose gel buffered in 0.5x TB (45 mM
Tris, 45mMboric acid). The gel was first stained with ethidium bromide and visualized using UV to analyze the DNA and, the same gel
was then stained with InstantBlue to analyze the protein.
For preparing sample for negative stain, the CoREST complex was mixed with nucleosome in a molar ratio of 3:1. The mixture was
incubated at room temperature for 2 hours and purified through a Superdex 200 (3.2/300) column with a fractionation size of 50 ml.
The sample from each fraction was analyzed on a 0.7% agarose gel in 0.5x TB buffer. The gel was stained with ethidium bromide and
visualized using UV. The fraction that contained the highest percentage of nucleosome:LHC in a 1:1 complex was selected, and
cross-linked with 0.01%glutaraldehyde. 5 ml of cross-linked sample was applied on glow discharged grid (carbon film 400mesh cop-
per grid, Agar Scientific). The sample was stained with 2.5% uranyl acetate for 1 min. The grid was visualized using a Talos F200C
200kV electron microscope at the MRC Toxicology Unit (Leicester). 384 micrographs were collected using a Ceta 16M CMOS cam-
era (total electron dose 30-40 e-/A˚2 for 1 s exposure). Micrographs were collected using FEI EPU software with defocus values of
1.0 mm, 1.5 mm, and 2.0 mm. Relion3.0 (Zivanov et al., 2018) was used for data analysis.
Cryo Electron Microscopy sample preparation and imaging
Preparation of cross-linked protein sample
The CoREST ternary complex was gel filtrated in buffer containing 25 mM HEPES and 50 mM potassium chloride. Protein was then
concentrated to 0.6 mg/ml or 0.8 mg/ml and mixed with glutaraldehyde (0.15%) or BS3 (4 mM) in a v/v ratio of 1:1. Reactions were
performed at room temperature for 5 minutes and stopped with a final concentration of 50 mM Tris.
Preparation of vitrified specimen
3 ml of 0.03 mg/ml sample was applied on the graphene oxide coated Quantifoil 300 mesh Au R1.2/1.3 grid. The sample was blotted
for 4 s after 30 s waiting time (4C, 100% humidity) with a blot force of 10 and then plunged into liquid ethane (FEI Vitrobot).
Data acquisition and processing
Datasets were collected on Titan Krios microscope operated at 300 kV equipped with a Gatan Quantum energy filter, a Gatan K2
summit direct electron camera (Gatan) and a Volta phase plate (Thermo Fisher Scientific). Movies were taken in EFTEM with a slit
width of 20 eV and at a nominal magnification of 105kx corresponding to a calibrated pixel size of 1.4 A˚ at the specimen level.
Each movie comprises 36 sub-frames with a total dose of 32 e-/A˚2, exposure time was 14 s with a dose rate of 4.47 e-/pixel/s on
the detector. Data acquisition was done using FEI EPU software at 0.5 mm defocus. For data acquisition without the Volta phase
plate, movies were taken at a nominal magnification of 130kx corresponding to a calibrated pixel size of 1.08 A˚ at the specimen level.
Each movie comprises 48 sub-frames with a total dose of 39 e-/A˚2, exposure time was 12 s with a dose rate of 3.857 e-/pixel/s on the
detector. Data acquisition was done using FEI EPU software at3.3 mm,3.0 mm,2.7 mmand2.4 mmdefocus. The frame images
of each micrograph were aligned and averaged for correction of beam-induced drift using MotionCor2 (Zheng et al., 2017). The local
motion within a micrograph was corrected using 53 5 patches without dose-weighting. The defocus values of the micrographs were
measured by Gctf-v1.06 (Zhang, 2016). SPHIRE-crYOLOwas used to pick particles (Wagner et al., 2019). Picked particles were then
analyzed and 3D model were generated using Relion3.0 (Zivanov et al., 2018).e7 Cell Reports 30, 2699–2711.e1–e8, February 25, 2020
QUANTIFICATION AND STATISTICAL ANALYSIS
Experimental Replicates and Quantification
All data are represented as SEM (standard error of the mean). There are 3 experimental replicates.
Statistical Analysis
All data are presented asmean ±SEMand analyzed using Prism (Graphpad). Student’s t test was used for single variable comparison
between two groups. Data are presented as ± SEM.
P values are shown in the form: *** p < 0.001, or **** p < 0.0001.
DATA AND CODE AVAILABILITY
The SAXs data is available from SASDB: SASDH45. The EM map of negative stained CoREST complex, cryoEM map of glutaralde-
hyde crosslinked CoREST complex, cryoEMmap of BS3 crosslinked CoREST complex (open and closed) and negative stain map of
the CoREST:nucleosome complex are available from EMDB: EMD-10626, EMDB: EMD-10627, EMDB: EMD-10628, EMDB:
EMD-10629, EMDB: EMD-10630. Unique materials are available from the authors.
FuDA is available from: https://www.ucl.ac.uk/hansen-lab/.Cell Reports 30, 2699–2711.e1–e8, February 25, 2020 e8
